Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Jenny Ling-Yu Chen, Chun-Kai Pan, Li-Cheng Lin, Ching-Yi Tsai, Ching-Ying Kuo, Yu-Sen Huang & Yu-Li Lin. (2023) Therapeutic efficacy of cyclin-dependent kinase inhibition in combination with ionizing radiation for lung cancer. International Journal of Radiation Biology 99:8, pages 1257-1266.
Read now
Read now
Rola El Sayed & Haidar El Darsa. (2022) Therapeutic modalities in small cell lung cancer: a paradigm shift after decades of quiescence. Expert Opinion on Pharmacotherapy 23:5, pages 583-597.
Read now
Read now
Articles from other publishers (15)
Xuelin Yun, Hailong Qin, Bin Du, Yu Peng, Yuling Liu, Yao Yuan, Jie Meng & Bixian Yang. (2023) Inhibitory effect and mechanism of hirsuteine on NCI‑H1299 lung cancer cell lines. Oncology Letters 25:5.
Crossref
Crossref
Isehaq Al-Huseini, Srinivasa Rao Sirasanagandla, Kondaveeti Suresh Babu, Ramakrishna Gopala Sumesh Sofin & Srijit Das. (2023) Kinase Inhibitors Involved in the Regulation of Autophagy: Molecular
Concepts and Clinical Implications. Current Medicinal Chemistry 30:13, pages 1502-1528.
Crossref
Crossref
Prashanth Ashok Kumar, Stephen L. Graziano, Natalie Danziger, Dean Pavlick, Eric A. Severson, Shakti H. Ramkissoon, Richard S. P. Huang, Brennan Decker & Jeffrey S. Ross. (2022)
Genomic landscape of non‐small‐cell lung cancer with methylthioadenosine phosphorylase (
MTAP
) deficiency
. Cancer Medicine 12:2, pages 1157-1166.
Crossref
Crossref
Ion G. Motofei. (2022) Biology of cancer; from cellular and molecular mechanisms to developmental processes and adaptation. Seminars in Cancer Biology 86, pages 600-615.
Crossref
Crossref
Xianhua Gu, Honghong Shen, Wenqi Bai, Zheng Xiang, Xinwei Li, Rong Zhang, Fan Shi, Huiyuan Li, Guangzheng Zhu & Suyang Guo. (2022) Endometrial cancer prognosis prediction using correlation models based on CDK family genes. Frontiers in Genetics 13.
Crossref
Crossref
Yuan Ke, Cheng-Gong Liao, Zheng-Qing Zhao, Xiao-Min Li, Rong-Jie Lin, Long Yang, He-Long Zhang & Ling-Min Kong. (2022) Combining a CDK4/6 Inhibitor With Pemetrexed Inhibits Cell Proliferation and Metastasis in Human Lung Adenocarcinoma. Frontiers in Oncology 12.
Crossref
Crossref
Panthita Kaewjanthong, Sarintip Sooksai, Hironobu Sasano, Gyorgy Hutvagner, Sarah Bajan, Eileen McGowan & Viroj Boonyaratanakornkit. (2022) Cell-penetrating peptides containing the progesterone receptor polyproline domain inhibits EGF signaling and cell proliferation in lung cancer cells. PLOS ONE 17:3, pages e0264717.
Crossref
Crossref
Deendyal Bhurta & Sandip B. Bharate. (2021) Analyzing the scaffold diversity of cyclin‐dependent kinase inhibitors and revisiting the clinical and preclinical pipeline. Medicinal Research Reviews 42:2, pages 654-709.
Crossref
Crossref
Guangyao Shan, Guoshu Bi, Yunyi Bian, Besskaya Valeria, Dejun Zeng, Huan Zhang, Guangyu Yao, Yi Zhang, Hong Fan & Cheng Zhan. (2022) Genomic And Tumor Microenvironment Differences Between Cell Cycle Progression Pathway Altered/Non-Altered Patients With Lung Adenocarcinoma. Frontiers in Oncology 12.
Crossref
Crossref
Sandeep Kumar Parvathareddy, Abdul K. Siraj, Tariq Masoodi, Padmanaban Annaiyappanaidu, Ismail A. Al-Badawi, Fouad Al-Dayel & Khawla S. Al-Kuraya. (2021) Cyclin-dependent kinase 9 (CDK9) predicts recurrence in Middle Eastern epithelial ovarian cancer. Journal of Ovarian Research 14:1.
Crossref
Crossref
Yong Yang, Guangda Yuan, Hongya Xie, Tengteng Wei, Donglin Zhu, Yimeng Zhu & Shiying Zheng. (2021) CDK14 expression is elevated in patients with non-small cell lung cancer and correlated with poor prognosis. Journal of International Medical Research 49:10, pages 030006052110131.
Crossref
Crossref
Jaqueline Ferreira Campos, Helder Freitas dos Santos, Thaliny Bonamigo, Nelson Luís de Campos Domingues, Kely de Picoli Souza & Edson Lucas dos Santos. (2021) Stingless Bee Propolis: New Insights for Anticancer Drugs. Oxidative Medicine and Cellular Longevity 2021, pages 1-18.
Crossref
Crossref
Jinmeng Zhang, Dayu Xu, Yue Zhou, Zhengfei Zhu & Xi Yang. (2021) Mechanisms and Implications of CDK4/6 Inhibitors for the Treatment of NSCLC. Frontiers in Oncology 11.
Crossref
Crossref
Win Sen Heng, Frank A. E. Kruyt & Shiau-Chuen Cheah. (2021) Understanding Lung Carcinogenesis from a Morphostatic Perspective: Prevention and Therapeutic Potential of Phytochemicals for Targeting Cancer Stem Cells. International Journal of Molecular Sciences 22:11, pages 5697.
Crossref
Crossref
Yongtao Li, Renle Du, Yongwei Nie, Tianqi Wang, Yakun Ma & Yan Fan. (2021) Design, synthesis and biological assessment of novel CDK4 inhibitor with potent anticancer activity. Bioorganic Chemistry 109, pages 104717.
Crossref
Crossref